Loading...
In 1991, synthetic EPO hit professional cycling like a bomb. The drug boosted red blood cell production by 10-15%, turning domestiques into climbers and climbers into champions. By 1996, an estimated 80% of the peloton was using it. There was no test. The UCI's only safeguard was a crude hematocrit cap of 50%—riders simply diluted their blood with saline before controls. Then the 1998 Festina affair blew the doors open: French police found 400 vials of EPO in team soigneur Willy Voet's car. Public outrage forced WADA's creation in 1999 and a urine EPO test by 2001. The arms race had begun. Teams pivoted to micro-dosing—small, frequent EPO injections that cleared the body in hours rather than days. Dr. Michele Ferrari taught riders to inject at night so morning tests showed nothing. When...
Popular framing: Cyclists doped because they were cheaters with no ethics.
Structural analysis: A Red Queen arms race: each detection method created selection pressure for the next evasion (micro-dosing, transfusions, gene doping), while the cost of getting caught fell on individuals and the profits from spectacular racing flowed to teams, sponsors, and organizers. Incentives at every level rewarded continuing to run; no actor inside the system could profitably stop, so the race kept escalating regardless of which riders filled the roles.
Framing the problem as individual moral failure directs reform energy toward punishment and character—interventions that cannot move a structural equilibrium. This gap matters because it ensures each generation of anti-doping reform will be outpaced by the next generation of evasion: until the prize structure changes, the game theory guarantees the Red Queen dynamic continues indefinitely.
